Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
Public ClinicalTrials.gov record NCT00308438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine whether an investigational compound, ALX-0600, is safe and effective in treating Crohn's Disease.
Study identification
- NCT ID
- NCT00308438
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Oct 31, 2005
- Completion
- May 31, 2006
- Last update posted
- May 13, 2021
2004 – 2006
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Clinical Therapeutics | Tucson | Arizona | 85712 | — |
| Rocky Mountain Gastroenterology | Lakewood | Colorado | 80401 | — |
| Rx Trials | Washington D.C. | District of Columbia | 20010 | — |
| Clinical Trials Management of Boca Raton | Boca Raton | Florida | 33486 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Venture Research | North Miami Beach | Florida | 33162 | — |
| Pinnacle Trials | Atlanta | Georgia | 30329 | — |
| Saint Joseph's Health System | Atlanta | Georgia | 30342 | — |
| Northwestern University School of Medicine | Chicago | Illinois | 60619 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| Asher Kornbluth, MD, PC | New York | New York | 10128 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Atilla Ertan | Houston | Texas | 77005 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| McGuire DVAMC | Richmond | Virginia | 23249 | — |
| Dean Foundation Research Center | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00308438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2021 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00308438 live on ClinicalTrials.gov.